Posted on April 29, 2019
Illinois Medicaid issues policy of coverage for Exondys51
We are happy to report that Illinois Medicaid now covers Exondys51 for ambulatory and non-ambulatory patients.
We remain committed to engaging with payers, both private and public, to ensure these reviews are done in a more timely manner. 2.5 years for a state to issue a policy of coverage on any DMD specific drug is unacceptable.
To view the coverage policy, click here: HERE.
Little Hercules Foundation relies on the generosity of individuals around the world, like you, who believe in our mission and in the power to make a difference in the lives of those diagnosed with — and families fighting against — Duchenne muscular dystrophy.